Article Information
History
- January 30, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Michael P. Castro, MD1,
- Jameson Quinn, PhD2,
- Asher Wasserman, PhD2,
- Alaa Awawda, BS2,
- Zachariah D. Cole, MS2,
- Mark A. Shapiro, MA, MBA2,
- Timothy J. Stuhlmiller, PhD2,* and
- Santosh Kesari, MD, PhD2,3
- 1Beverly Hills Cancer Center, Beverly Hills, CA
- 2xCures Inc., Oakland, CA
- 3Pacific Neuroscience Institute, Providence Saint John’s Health Center, Santa Monica, CA
- ↵*Corresponding author Timothy J. Stuhlmiller, 1901 Harrison Street, Suite 1100, Oakland, CA 94612, tstuhlmiller{at}xcures.com
Posted January 30, 2024.
Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma multiforme: results from a nationwide real-world evidence database
